Health
FDA Approval Helps Immunocompromised Shingles Sufferers – Infection Control Today
Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved…
Adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression have been given another means to fight the disease thanks to the approval by the US Food and Drug Administration (FDA) of the non-live, recombinant sub-unit adjuvanted…
Continue Reading
-
Business19 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business15 hours agoDicker Data rides the AI trend to double digit growth
-
Business23 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Noosa News16 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference